,"This is a citation overview for a set of 20 documents.",,,,,,,,,,,,
,,,,,,,,,,,,,
,"h index = 13 (Of the 20 documents considered for the h-Index, 13 have been cited at least 13 times.)",,,,,,,,,,,,
,Note: Scopus does not have complete citation information for articles published before 1996.  ,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,<2010,2010,2011,2012,subtotal,>2012,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,395,156,182,59,397,0,792
2009,"Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand","Pandey S., Newton S., Upton A., Roberts S., Drinkovi D.",00313025,"Pathology",41, 6,0,1,3,1,5,0,5
2009,"1?,25-dihydroxyvitamin D 3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection","Coussens A., Timms P.M., Boucher B.J., Venton T.R., Ashcroft A.T., Skolimowska K.H., Newton S.M., Wilkinson K.A., Davidson R.N., Griffiths C.J., Wilkinson R.J., Martineau A.R.",00192805,"Immunology",127, 4,1,7,13,3,23,0,24
2009,"Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis","Wilkinson K.A., Wilkinson R.J., Newton S.M., Stewart G.R., Martineau A.R., Patel J., Sullivan S.M., Herrmann J.-L., Neyrolles O., Young D.B.",14712180,"BMC Microbiology",9, ,0,0,1,0,1,0,1
2009,"Evolution of central nervous system multidrug-resistant Mycobacterium tuberculosis and late relapse of cryptic prosthetic hip joint tuberculosis: Complications during treatment of disseminated isoniazid-resistant tuberculosis in an immunocompromised host","Upton A., Woodhouse A., Vaughan R., Newton S., Ellis-Pegler R.",00951137,"Journal of Clinical Microbiology",47, 2,1,2,1,0,3,0,4
2008,"Paediatric tuberculosis","Newton S.M., Brent A.J., Anderson S., Whittaker E., Kampmann B.",14733099,"The Lancet Infectious Diseases",8, 8,20,26,34,13,73,0,93
2008,"Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients","Newton S.M., Mackie S.L., Martineau A.R., Wilkinson K.A., Kampmann B., Fisher C., Dutta S., Levin M., Wilkinson R.J., Pasvol G.",15566811,"Clinical and Vaccine Immunology",15, 3,4,0,3,0,3,0,7
2007,"IFN-?- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37 (Journal of Immunology (2007) 178 (7190-7198))","Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., Davidson R.N., Sorensen O.E., Kampmann B., Griffiths C.J., Wilkinson R.J.",00221767,"Journal of Immunology",179, 12,0,1,0,0,1,0,1
2007,"A single dose of vitamin D enhances immunity to mycobacteria","Martineau A.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Kampmann B., Hall B.M., Packe G.E., Davidson R.N., Eldridge S.M., Maunsell Z.J., Rainbow S.J., Berry J.L., Griffiths C.J.",1073449X,"American Journal of Respiratory and Critical Care Medicine",176, 2,67,27,33,14,74,0,141
2007,"Neutrophil-mediated innate immune resistance to mycobacteria","Martineau A.R., Newton S.M., Wilkinson K.A., Kampmann B., Hall B.M., Nawroly N., Packe G.E., Davidson R.N., Griffiths C.J., Wilkinson R.J.",00219738,"Journal of Clinical Investigation",117, 7,27,18,20,8,46,0,73
2007,"IFN-?- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37","Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., Davidson R.N., Sorensen O.E., Kampmann B., Griffiths C.J., Wilkinson R.J.",00221767,"Journal of Immunology",178, 11,41,18,27,6,51,0,92
2007,"Erratum: A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion (Proceedings of the National Academy of Sciences of the United States of America (October 17, 2006) 103, 42 (15594-15598) DOI: 10.1073/pnas.0604283103))","Newton S.M., Fandrich S., Smallie T., Foxwell B., Al-Obaidi A., Shafi J., Rajakumar K., Kampmann B., Andrew P.W., Ziegler-Heitbrock L., Barer M.R., Smith R.J., Wilkinson R.J., Wilkinson K.A., Nicol M.P., Garton N.J., Staples K.J., Stewart G.R., Wain J.R., Martineau A.R.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",104, 2,0,0,0,0,0,0,0
2006,"A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion","Newton S.M., Fandrich S., Smallie T., Foxwell B., Al-Obaidi A., Shafi J., Rajakumar K., Kampmann B., Andrew P.W., Ziegler-Heitbrock L., Barer M.R., Smith R.J., Wilkinson R.J., Wilkinson K.A., Nicol M.P., Garton N.J., Staples K.J., Stewart G.R., Wain J.R., Martineau A.R.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",103, 42,23,7,10,4,21,0,44
2006,"Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing","Anderson S.T., Wilkinson K.A., Williams A.J., Brown J.R., Newton S.M., Simsova M., Nicol M.P., Sebo P., Levin M., Wilkinson R.J.",1073449X,"American Journal of Respiratory and Critical Care Medicine",173, 9,21,1,0,0,1,0,22
2006,"Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens","Wilkinson K.A., Kon O.M., Newton S.M., Meintjes G., Davidson R.N., Pasvol G., Wilkinson R.J.",00221899,"Journal of Infectious Diseases",193, 3,41,10,6,0,16,0,57
2005,"Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis","Stewart G.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Sullivan S.M., Neyrolles O., Wain J.R., Patel J., Pool K.-L., Young D.B.",00199567,"Infection and Immunity",73, 10,12,1,2,0,3,0,15
2005,"Infection biology of a novel ?-crystallin of Mycobacterium tuberculosis: Acr2","Wilkinson K.A., Stewart G.R., Newton S.M., Vordermeier H.M., Wain J.R., Murphy H.N., Horner K., Young D.B., Wilkinson R.J.",00221767,"Journal of Immunology",174, 7,23,4,3,1,8,0,31
2005,"The stress-responsive chaperone ?-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis","Stewart G.R., Newton S.M., Wilkinson K.A., Humphreys I.R., Murphy H.N., Robertson B.D., Wilkinson R.J., Young D.B.",0950382X,"Molecular Microbiology",55, 4,20,7,2,2,11,0,31
2002,"The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis","Newton S.M., Lau C., Gurcha S.S., Besra G.S., Wright C.W.",03788741,"Journal of Ethnopharmacology",79, 1,54,17,11,2,30,0,84
2000,"In-vitro antimycobacterial screening of some plant species used in traditional medicine for the treatment of tuberculosis","Newton S.M., Lau C., Wright C.W.",00223573,"Journal of Pharmacy and Pharmacology",52, 9,0,0,0,0,0,0,0
2000,"A review of antimycobacterial natural products","Newton S.M., Lau C., Wright C.W.",0951418X,"Phytotherapy Research",14, 5,40,9,13,5,27,0,67
